Prevention of dopamine-induced cell death by thiol antioxidants: Possible implications for treatment of Parkinson's disease

Experimental Neurology

Volumn 141, Issue 1, 1996, Pages 32-39

  Offen, Daniel ^a,b   Ziv, Ilan ^a,b   Sternin, Hagit ^b   Melamed, Eldad ^a,b   Hochman, Ayala ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; BUTHIONINE SULFOXIMINE; DITHIOTHREITOL; DOPAMINE; GLUTATHIONE; THIOL DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DNA SYNTHESIS; NONHUMAN; PARKINSON DISEASE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RAT;

EID: 0030249286     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0136     Document Type: Article

References (34)

1. 1. ADAMS, J. D., JR., AND I. N. ODUNZE. 1991. Oxygen free radicals and Parkinson's disease. Free Rad. Biol. Med. 10: 161-169.
2. 2. ARUMA, O. I., B. HALLIWELL, B. M. HOEY, AND J. BUTLER. 1990. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Rad. Biol. Med. 6: 593-597.
3. 3. BINDOLI, A., M. P. RIGOBELLO, AND D. J. DEEBLE. 1992. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Rad. Biol. Med. 13: 391-405.
4. 4. COHEN, G., AND M. B. SPINA. 1989. Deprenyl suppress the oxidant stress associated with increased dopamine turnover. Ann. Neurol. 26: 698-690.
5. 5. DEXTER, D. T., P. JENNER, A. H. SCHAPIRA, AND C. D. MARSDEN. 1992. Alteration in levels of iron, ferritin, and other trace metal in neurogenerative disease affecting the basalganglia. Ann. Neurol. 32: S94-100.
6. 6. DEXTER, D. T., C. J. CARTER, F. R. WELLS, F. JAVOY-AGID, Y. JAVOY, A. LEES, AND P. JENNER. 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52: 381-389.
7. 7. FAHN, S., AND THE PARKINSON STUDY GROUP. 1993. Effects of tocopherol and deprenyl on progression of disability in early Parkinsons disease. N. Engl. J. Med. 328: 176-183.
8. 8. FERRARI, G., C. Y. YAN, AND L. A. GREENE. 1995. N-Acetylcysteine (D-and L-stereoisomers) prevents apoptotic death of neuronal cells. J. Neurosci. 15: 2857-2866.
9. 9. GARDINER, C. S., AND D. J. REED. 1995. Synthesis of glutathione in the preimplantation mouse embryo. Arch. Biochem. Biophys. 318: 30-36.
10. 10. GAVRIELI, Y., Y. SHERMAN, AND S. A. BEN-SASSON. 1992. Identification of programmed death in situ via labeling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501.
11. 11. GOTZ, M. E., A. FREYBERGER, AND P. RIEDERER. 1990. Oxidative stress: A role in the pathogenesis Parkinson's disease. J. Neural. Transm. Suppl. 29: 241-249.
12. 12. GOTZ, M. E., G. KUNIG, P. RIEDERER, AND M. B. H. YOUDIM. 1994. Oxidative stress: Free radical production in neural degeneration. Pharmacol. Ther. 63: 37-122.
13. 13. HURD, R. W., B. J. WILDER, C. E. PIPPENGER, W. R. HELVESTON, AND B. M. UTHMAR. 1994. Treatment of neurodegenerative disease with N-acetylcysteine. Movement Disord. 9 (Supplement 1). [Abstract]
14. 14. JELLINGER, P., E. KIENZL, G. RUMPELMAIR, D. STACHELBERGER, BEN-SHACHAR, AND M. B. H. YOUDIM. 1992. Iron-melanin complex in substantia nigra: Cause of Parkinson's disease. J. Neurochem. 59: 1168-1171.
15. 15. JONES, P. D. 1995. Glutathione distribution in natural products: Absorption and tissue distribution. Methods Enzymol. 252: 3-25.
16. 16. KOPIN, I. J. 1985. Catecholamine metabolism: Basic aspects and clinical significance. Pharm. Rev. 37: 333-386.
17. 17. MYTILINEOU, C., S-K HAN, AND G. COHEN. 1993. Toxic and protective effects of L-DOPA on mesencephalic cell cultures. J. Neurochem. 61: 1470-1478.
18. 18. OFFEN, D., I. ZIV, S. GORODIN, Z. MALIK, A. BARZILAI, AND E. MELAMED. 1995a. Dopamine-induced programmed cell death in mouse thymocytes. Biochem. Biophys. Acta 1268: 171-177.
19. 19. OFFEN, D., I. ZIV, H. PANET, L. WASSERMAN, R. STEIN, E. MELAMED, AND A. BARZILAI. 1996. Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2: Evidence that the proto-oncogene may act as an antioxidant. Mol. Cell Neurobiol., in press.
20. 20. PERRY, T. L., AND YONG. 1986. Idiopathic Parkinson's disease, progressive supernuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 30: 269-227.
21. 21. PILEBLAD, E., T. MAGNUSSON, AND B. FORNSTEDT. 1989. Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum. J. Neurochem. 52: 978-980.
22. 22. PILEBLAD, E., A. SLIVKA, D. BRATVOLD, AND G. COHEN. 1988. Studies on the autoxidation of dopamine: Interaction with ascorbate. Arch. Biochem. Biophys. 263: 447-452.
23. 23. REILLY, D. K., L. HERSHEY, L. RIVERAI-CALIMLIM, AND I. SHOULSON. 1983. On-off effects in Parkinson's disease: A controlled investigation of ascorbic acid therapy. Adv. Neurol. 37: 51-60.
24. 24. RIEDERER, P., E. SOFIC, AND W. D. RAUSCH. 1989. Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brain. J. Neurochem. 52: 525-520.
25. 25. SCHAPIRA, A. H., A. HARTLEY, M. W. CLEETER, AND J. M. COOPER. 1993. Free radicals and mitochondrial dysfunction in Parkinson's disease. Biochem. Soc. Trans. 21: 367-370.
26. 26. SIAN, J., D. T. DEXTER, A. J. LESS, S. DANIEL, Y. AGID, F. JAVOY-AGID, P. JENNER, AND C. D. MARSDEN. 1994. Alteration in Glutathione levels in Parkinson's disease and other neurogenerative disorders affecting basal ganglia. Ann-Neurol. 36: 348-355.
27. 27. SIAN, J., D. T. DEXTER, A. J. LESS, S. DANIEL, P. JENNER, AND C. D. MARSDEN. 1994. Glutathione-related enzymes in brain in Parkinson's disease. Ann. Neurol. 36: 356-361.
28. 28. SLIVKA, A., M. B. SPINA, AND G. COHEN. 1987. Reduced and oxidized glutathione in human and monkey brain. Neurosci. Lett. 74: 112-118.
29. 29. SOFIC, E. W., K. PAULUS, P. JELLINGER, P. RIEDERER, AND M. B. H. YOUDIM. 1991. Selective increase of iron in substantia nigra zona compacta in Parkinsonian brain. J. Neurochem. 56: 978-982.
30. 30. TANAKA, M., A. SOTOMATSU, H. KANAI, AND S. HIRAI. 1991. Dopa and dopamine cause cultured neuronal death in the presence of iron. J. Neurol. Sci. 101: 198-203.
31. 31. VINCENT, M., M. LAFLEUR, J. J. HOORWEG, H. JOENJE, E. J. WESTMIJZE, AND J. RETEL. 1994. The ambivalent role of glutathione in the protection of DNA against singlet oxygen. Free Rad. Res. 21: 9-17.
32. 2 toxicity by N-acetylcysteine. Eur. Resp. J. 2: 116-126.
33. 33. WICK, M. M. 1978. Dopamine: A novel antitumor agent active against B-16 melanoma in vivo. J. Invest. Dermatol. 71: 163-164.
34. 34. ZIV, I., E. MELAMED, N. NARDI, D. LURIA, A. ACHIRON, D. OFFEN, AND A. BARZILAI. 1994. Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - A possible novel pathogenic mechanism in Parkinson's disease. Neurosci. Lett. 170: 136-140.